FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PERSERIS (risperidone) from Indivior Inc., indicating a modification to the product’s approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERSERIS (RISPERIDONE)

Snippet

SUPPL AP for PERSERIS (RISPERIDONE)